PAR Equity Snapshot

MEDCL Weekly Equity Report

MedinCell S.A.

Latest Close 27.42 EUR 12 Jun 2026
1W Return 2.2% latest completed week
4W Return 0.1% short-term follow-through
12W Return 35.5% quarterly tape
Trend Breadth 59.6% 31 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. …

Snapshot

What the weekly tape is saying

MEDCL closed the latest completed week at 27.42 EUR. The 4-week return is 0.1% and the 12-week return is 35.5%. Trend Signal is inactive, Market Dynamics is 0.99. Setup signature: Deep recovery attempt with a 53/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 9.4%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 33 Persistence of active Trend Signal over the last year and current streak.
Momentum 82 Blend of 4-week and 12-week follow-through.
Dynamics 77 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 79 Relative leadership and short-term RS change.
Volume 34 Participation compared with the 13-week volume baseline.
Risk Control 15 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
25.06 EUR
Vs Trend Line
9.4%
Fair Value
16.00 EUR
Vs Fair Value
71.3%
52W High
39.68 EUR
52W Low
15.00 EUR
Drawdown
-30.9%
Range Position
50.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 2.2%
4W 0.1%
12W 35.5%
26W -0.5%
52W 77.5%

Trend read

Active Streak
0 weeks
52W Active Weeks
31
52W Active Breadth
59.6%
Sector Scope
FR Healthcare
Sector Rank
11 of 76
Sector Percentile
86.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.99
4W MD Change
112.6%
Relative Strength
10.88
4W RS Change
-46.1%
Expectation
Positive
Probability
58.22%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
415.4K
13W Average
509.3K
52W Average
581.4K
Vs 13W
0.8x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.1%
52W Volatility
8.0%
Upside Weeks
29
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
6.7% / -5.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
PAR
Country
FR
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
1.0B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 27.42 EUR 2.2% 25.06 EUR 16.00 EUR 0.99 10.88 415.4K Off
5 Jun 2026 26.84 EUR -5.0% 25.16 EUR 15.87 EUR 1.08 11.20 646.0K Off
29 May 2026 28.26 EUR 4.0% 25.32 EUR 15.75 EUR 1.06 18.51 635.9K Off
22 May 2026 27.18 EUR -0.7% 25.66 EUR 15.61 EUR 0.79 15.93 524.5K Off
15 May 2026 27.38 EUR 4.4% 25.96 EUR 15.48 EUR 0.46 20.17 575.5K Off
8 May 2026 26.22 EUR 6.2% 26.17 EUR 15.35 EUR 0.08 13.96 591.1K Off
1 May 2026 24.68 EUR 6.6% 26.21 EUR 15.22 EUR -0.38 8.14 603.9K Off
24 Apr 2026 23.16 EUR -4.5% 26.28 EUR 15.12 EUR -0.65 1.67 506.3K Off
17 Apr 2026 24.26 EUR 4.5% 26.25 EUR 15.03 EUR -0.76 3.73 476.3K Off
10 Apr 2026 23.22 EUR 0.5% 26.15 EUR 14.93 EUR -0.97 1.94 361.0K Off
3 Apr 2026 23.10 EUR 4.1% 26.05 EUR 14.84 EUR -1.06 5.94 267.5K Off
27 Mar 2026 22.20 EUR 9.7% 25.84 EUR 14.76 EUR -1.18 6.04 534.8K Off
20 Mar 2026 20.24 EUR -0.5% 25.68 EUR 14.68 EUR -1.19 -2.17 482.5K Off
13 Mar 2026 20.34 EUR -4.6% 25.60 EUR 14.60 EUR -1.16 -4.22 546.4K Off